Oruka Therapeutics, Inc. (ORKA)
US$ 26.684.14%
Price Chart
Key Statistics
Market Cap
$ 888.26M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
159K
52W High
$ 33.00
52W Low
$ 5.49
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
35.2382
200-Day MA
30.9298
52 Week High
33
52 Week Low
5.49
About ORKA
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indi.
Employees
28
Headquarters
Menlo Park, CA
CEO
Dr. Lawrence Otto Klein Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg